China Life Insurance Co Renews Framework Agreement with AMP
China Life Insurance Co (HK:2628) has renewed its Framework Agreement with AMP, allowing continued connected transactions until December 31, 2025. This includes fund product subscriptions and private asset management, subject to Hong Kong and SSE Listing Rules. The latest analyst rating for HK:2628 is a Buy with a price target of HK$31.00. China Life is a major player in the insurance sector, primarily in China, with a market cap of HK$1170.9B and an average trading volume of 74,677,873 shares.
China Life Insurance Co ( (HK:2628) ) has shared an update.
China Life Insurance Co has announced the renewal of its continuing connected transactions with AMP, a subsidiary of its associate company, under a new Framework Agreement set to be finalized by December 31, 2025. This agreement will allow CLI to continue its daily transactions with AMP, including the subscription and redemption of fund products and private asset management. The transactions are subject to specific reporting and approval requirements under the Hong Kong and SSE Listing Rules, given the significant cumulative transaction amount between the involved parties.
The most recent analyst rating on (HK:2628) stock is a Buy with a HK$31.00 price target. To see the full list of analyst forecasts on China Life Insurance Co stock, see the HK:2628 Stock Forecast page.
More about China Life Insurance Co
China Life Insurance Co is a major player in the insurance industry, primarily offering life insurance products and services. The company is focused on the Chinese market and operates as a joint stock limited company incorporated in the People’s Republic of China. It is a significant entity in the financial services sector, with a controlling shareholder, CLIC, holding a substantial 68.37% of its issued share capital.
Average Trading Volume: 74,677,873
Technical Sentiment Signal: Buy
Current Market Cap: HK$1170.9B
For an in-depth examination of 2628 stock, go to TipRanks’ Overview page.
